BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 06, 2007
 |  BioCentury  |  Regulation

Tysabri & infection

Tysabri & infection

Tysabri & infection
Eleven opportunistic and other uncommon infections were seen in Crohn's disease patients who received Tysabri in clinical trials, while none occurred in patients on placebo. Three patients died after contracting...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >